Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Optimal Serum TSH Concentration During Thyroxine Treatment for Primary Hypothyroidism? Effects of Fine Titration of Thyroxine Dosage on Wellbeing, Quality of Life and Cognitive Function

NCT00111735 is registered in ClinicalTrials.gov with Sir Charles Gairdner Hospital as lead sponsor.

NCT NCT00111735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00111735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Optimal Serum TSH Concentration During Thyroxine Treatment for Primary Hypothyroidism? Effects of Fine Titration of Thyroxine Dosage on Wellbeing, Quality of Life and Cognitive Function
Lead sponsor
Sir Charles Gairdner Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2003
Completion date
March 31, 2005
Enrollment
55
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypothyroidism